RxSight, Inc.
RXST· Nasdaq
Released Aug 8, 2022, after the close
10-Q filed Aug 8, 2022, 39 days after period end · 0000950170-22-015528
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $11.36M | $4.90M | $2.71M |
| Net Income | -$16.73M | -$13.48M | -$12.88M |
| EPS Diluted | -$0.61 | -$3.53 | $0.00 |
RxSight, Inc. · CIK 1111485 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.